你即將離開本站

並前往https://www.astrazeneca.com/media-centre/press-releases/2021/lynparza-propel-trial-meets-primary-endpoint.html

Lynparza in combination with abiraterone significantly ...

Lynparza in combination with abiraterone significantly delayed disease progression in all-comers in PROpel Phase III trial in 1st-line ...

確定！ 回上一頁

查詢 「Comers」的人也找了：

  1. comers中文
    2.
  2. Comers
    3.
  3. New comer
    4.
  4. Comercial
    5.
  5. comer動詞變化
    6.
  6. newcomer中文
    7.
  7. Newcomer
    8.
  8. Corner
    9.